Literature DB >> 20689994

Bone age and factors affecting skeletal maturation at diagnosis of paediatric Cushing's disease.

Shrikrishna V Acharya1, Raju A Gopal, Anurag Lila, Padma S Menon, Tushar R Bandgar, Nalini S Shah.   

Abstract

Paediatric Cushing's disease (CD) is usually associated with growth retardation, but there are only few published data on skeletal maturation at diagnosis. We analysed factors contributing to skeletal maturation and final height in Asian Indian patients with paediatric CD. We conducted retrospective analysis of 48 patients (29 males; 19 females) with mean age: 14.84 years at diagnosis (range 9-19 years). A single observer using the Greulich Pyle method determined the bone age (BA) of each child. BA delay, i.e. the difference between chronological age (CA) and BA, was compared with clinical and biochemical variables. BA delay was present in 35/48 (73%) patients (mean delay 1.6 years, range 0.5-5 years) and correlated negatively with height SDS (r = -0.594, P < 0.001) and positively with CA at diagnosis (r = 0.247, P < 0.05). There was no correlation with duration of symptoms before diagnosis, basal cortisol, midnight cortisol, ACTH or percentage suppression of low dose dexamethasone suppression cortisol (LDDST). We could not demonstrate any relationship between the duration of history before diagnosis and height SDS at final height. Mean final height SDS in patients was -1.84. We found that most children with CD had delayed BA and correlated significantly with CA and height SDS at diagnosis. Early diagnosis may reduce delay in skeletal maturation and thus contribute to optimal catch-up growth.

Entities:  

Mesh:

Year:  2010        PMID: 20689994     DOI: 10.1007/s11102-010-0246-3

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  18 in total

Review 1.  Diagnosis and complications of Cushing's syndrome: a consensus statement.

Authors:  G Arnaldi; A Angeli; A B Atkinson; X Bertagna; F Cavagnini; G P Chrousos; G A Fava; J W Findling; R C Gaillard; A B Grossman; B Kola; A Lacroix; T Mancini; F Mantero; J Newell-Price; L K Nieman; N Sonino; M L Vance; A Giustina; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

2.  Growth retardation in Cushing's syndrome.

Authors:  A L Strickland; L E Underwood; S J Voina; F S French; J J Van Wyk
Journal:  Am J Dis Child       Date:  1972-03

3.  Final adult height and body mass index after cure of paediatric Cushing's disease.

Authors:  J H Davies; H L Storr; K Davies; J P Monson; G M Besser; F Afshar; P N Plowman; A B Grossman; M O Savage
Journal:  Clin Endocrinol (Oxf)       Date:  2005-04       Impact factor: 3.478

4.  Glucocorticoids inhibit vascular endothelial growth factor expression in growth plate chondrocytes.

Authors:  Joost A Koedam; Jeske J Smink; Sylvia C van Buul-Offers
Journal:  Mol Cell Endocrinol       Date:  2002-11-29       Impact factor: 4.102

5.  Factors influencing skeletal maturation at diagnosis of paediatric Cushing's disease.

Authors:  C J Peters; M L Ahmed; H L Storr; K M Davies; L J Martin; J Allgrove; A B Grossman; M O Savage
Journal:  Horm Res       Date:  2007-03-28

6.  Abnormal puberty in paediatric Cushing's disease: relationship with adrenal androgen, sex hormone binding globulin and gonadotrophin concentrations.

Authors:  C C Dupuis; H L Storr; L A Perry; J T F Ho; L Ahmed; K K Ong; D B Dunger; J P Monson; A B Grossman; G M Besser; M O Savage
Journal:  Clin Endocrinol (Oxf)       Date:  2007-04-15       Impact factor: 3.478

7.  Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure.

Authors:  M A Magiakou; G Mastorakos; M T Gomez; S R Rose; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1994-01       Impact factor: 5.958

8.  Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes.

Authors:  C Jux; K Leiber; U Hügel; W Blum; C Ohlsson; G Klaus; O Mehls
Journal:  Endocrinology       Date:  1998-07       Impact factor: 4.736

Review 9.  Androgens and bone.

Authors:  Dirk Vanderschueren; Liesbeth Vandenput; Steven Boonen; Marie K Lindberg; Roger Bouillon; Claes Ohlsson
Journal:  Endocr Rev       Date:  2004-06       Impact factor: 19.871

10.  Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits.

Authors:  J Baron; Z Huang; K E Oerter; J D Bacher; G B Cutler
Journal:  Am J Physiol       Date:  1992-09
View more
  3 in total

1.  Skeletal maturation in children with Cushing syndrome is not consistently delayed: the role of corticotropin, obesity, and steroid hormones, and the effect of surgical cure.

Authors:  Maya B Lodish; Evgenia Gourgari; Ninet Sinaii; Suvimol Hill; Laura Libuit; Spyridon Mastroyannis; Margaret Keil; Dalia L Batista; Constantine A Stratakis
Journal:  J Pediatr       Date:  2014-01-10       Impact factor: 4.406

2.  The effect of steroid treatment and thymectomy on bone age and height development in juvenile myasthenia gravis.

Authors:  Haiyan Wang; Zhe Su; Chuanming Luo; Yan Li; Huiyu Feng; Wei Fang; Chunyan Du; Juan Deng; Fei Yu; Weibin Liu
Journal:  Neurol Sci       Date:  2013-04-26       Impact factor: 3.307

Review 3.  Paediatric Cushing's disease: Epidemiology, pathogenesis, clinical management and outcome.

Authors:  Rosario Ferrigno; Valeria Hasenmajer; Silvana Caiulo; Marianna Minnetti; Paola Mazzotta; Helen L Storr; Andrea M Isidori; Ashley B Grossman; Maria Cristina De Martino; Martin O Savage
Journal:  Rev Endocr Metab Disord       Date:  2021-01-30       Impact factor: 6.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.